AU7717598A - Control of immune responses by modulating activity of glycosyltransferase - Google Patents

Control of immune responses by modulating activity of glycosyltransferase

Info

Publication number
AU7717598A
AU7717598A AU77175/98A AU7717598A AU7717598A AU 7717598 A AU7717598 A AU 7717598A AU 77175/98 A AU77175/98 A AU 77175/98A AU 7717598 A AU7717598 A AU 7717598A AU 7717598 A AU7717598 A AU 7717598A
Authority
AU
Australia
Prior art keywords
immune responses
glycosyltransferase
control
modulating activity
inhibiting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU77175/98A
Other languages
English (en)
Inventor
Jamey D. Marth
James C Paulson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California
Cytel Corp
Original Assignee
University of California
Cytel Corp
University of California Berkeley
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of California, Cytel Corp, University of California Berkeley filed Critical University of California
Publication of AU7717598A publication Critical patent/AU7717598A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C12N15/1137—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against enzymes
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0271—Chimeric vertebrates, e.g. comprising exogenous cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1048—Glycosyltransferases (2.4)
    • C12N9/1081—Glycosyltransferases (2.4) transferring other glycosyl groups (2.4.99)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Environmental Sciences (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Animal Husbandry (AREA)
  • Cell Biology (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Medicines Containing Plant Substances (AREA)
AU77175/98A 1997-05-30 1998-05-29 Control of immune responses by modulating activity of glycosyltransferase Abandoned AU7717598A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US4830397P 1997-05-30 1997-05-30
US60048303 1997-05-30
PCT/US1998/011260 WO1998054365A1 (en) 1997-05-30 1998-05-29 Control of immune responses by modulating activity of glycosyltransferases

Publications (1)

Publication Number Publication Date
AU7717598A true AU7717598A (en) 1998-12-30

Family

ID=21953820

Family Applications (1)

Application Number Title Priority Date Filing Date
AU77175/98A Abandoned AU7717598A (en) 1997-05-30 1998-05-29 Control of immune responses by modulating activity of glycosyltransferase

Country Status (7)

Country Link
US (2) US6376475B1 (https=)
EP (1) EP1017846B1 (https=)
JP (2) JP4451933B2 (https=)
AT (1) ATE371041T1 (https=)
AU (1) AU7717598A (https=)
DE (1) DE69838298T2 (https=)
WO (1) WO1998054365A1 (https=)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7192914B1 (en) * 1999-09-30 2007-03-20 The Regents Of The University Of California Prevention of atherosclerosis and undesired blood clotting by reducing von Willebrand factor
AU7834800A (en) * 1999-09-30 2001-04-30 Regents Of The University Of California, The Prevention of atherosclerosis and undesired blood clotting by reducing von willebrand factor
DE60140903D1 (de) 2000-10-18 2010-02-04 Brigham & Womens Hospital E-selectin/l-selectin-liganden-polypeptide hämatopoetischer zellen und verfahren zu deren verwendung
US20060210558A1 (en) * 2000-10-18 2006-09-21 Robert Sackstein Hematopoietic cell selectin ligand polypeptides and methods of use thereof
DE60215530T2 (de) * 2001-08-16 2007-05-31 Daiichi Asubio Pharma Co., Ltd. Neues glykolipid, und heilmittel für autoimmunerkrankungen, das dieses als wirkstoff enthält
US20060074047A1 (en) * 2004-10-06 2006-04-06 Cross Alan S Method of treating inflammation with inhibitors of sialyl transferases
JP4359779B2 (ja) * 2006-01-23 2009-11-04 ソニー株式会社 音響再生装置および音響再生方法
GB0614947D0 (en) * 2006-07-27 2006-09-06 Isis Innovation Epitope reduction therapy
US8163551B2 (en) 2008-05-02 2012-04-24 Seattle Genetics, Inc. Methods and compositions for making antibodies and antibody derivatives with reduced core fucosylation
DK2608796T3 (en) * 2010-08-05 2019-03-18 Seattle Genetics Inc Inhibition of protein fucosylation in vivo using fucose analogues
WO2012080975A1 (en) * 2010-12-16 2012-06-21 Basf Se Plants having increased tolerance to herbicides
JP2014159374A (ja) * 2011-05-20 2014-09-04 Nippon Nohyaku Co Ltd 作物の枯凋落葉剤組成物
AR091489A1 (es) * 2012-06-19 2015-02-11 Basf Se Plantas que tienen una mayor tolerancia a herbicidas inhibidores de la protoporfirinogeno oxidasa (ppo)
WO2014031875A1 (en) 2012-08-23 2014-02-27 Seattle Genetics, Inc. Treatment of sickle cell disease and inflammatory conditions
JP2016027002A (ja) * 2012-11-16 2016-02-18 日本農薬株式会社 除草剤組成物
JP6172687B2 (ja) 2013-05-02 2017-08-02 国立研究開発法人産業技術総合研究所 シアリル化糖鎖を認識するモノクローナル抗体
EP3033416A4 (en) * 2013-08-12 2017-02-08 Benaroya Research Institute at Virginia Mason 4-methylumbelliferone treatment for immune modulation

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5352462A (en) * 1982-06-03 1994-10-04 Stolle Research & Development Corporation Anti-inflammatory factor, method of isolation, and use
US5288854A (en) * 1990-11-28 1994-02-22 Center For Blood Research, Inc. Functional derivatives of ICAM-1 which are substantially capable of binding to LFA-1 but are substantially incapable of binding to MAC-1
US5461143A (en) * 1991-03-18 1995-10-24 The Scripps Research Institute Oligosaccharide enzyme substrates and inhibitors: methods and compositions
JPH05247078A (ja) 1992-03-03 1993-09-24 Japan Tobacco Inc 糖化合物、シアル酸含有糖鎖類生合成阻害剤、その製造方法、並びに新規な中間体
US5453272A (en) 1992-10-02 1995-09-26 Alberta Research Council Lectin derived carbohydrate binding-peptide
WO1995034202A1 (en) 1994-06-15 1995-12-21 Alexion Pharmaceuticals, Inc. Methods for reducing hyperacute rejection of xenografts
WO2002028391A1 (en) * 2000-10-06 2002-04-11 The Regents Of The University Of California Blocking inflammation by inhibiting sialylation

Also Published As

Publication number Publication date
EP1017846A4 (en) 2004-08-11
JP2002528037A (ja) 2002-08-27
DE69838298D1 (de) 2007-10-04
EP1017846B1 (en) 2007-08-22
US6376475B1 (en) 2002-04-23
US20030013636A1 (en) 2003-01-16
JP4451933B2 (ja) 2010-04-14
EP1017846A1 (en) 2000-07-12
ATE371041T1 (de) 2007-09-15
DE69838298T2 (de) 2008-05-15
WO1998054365A1 (en) 1998-12-03
JP2002528036A (ja) 2002-08-27

Similar Documents

Publication Publication Date Title
AU7717598A (en) Control of immune responses by modulating activity of glycosyltransferase
IL143748A0 (en) Substituted aryl or heteroarylamides having retinoid-like biological activity
IL122859A0 (en) Cell-free synthesis of polyketides
IL125785A0 (en) Farnesyl transferase inhibitors
AU2586895A (en) Compounds for inhibiting osteoclast-mediated bone resorption
TR199700726T1 (xx) Farnezil transferaz �nleyiciler ve m�stahzarlar�.
WO1994025612A3 (fr) Sequences de nucleotides pour le controle de l'expression de sequences d'adn dans un hote cellulaire
ES2114487B1 (es) Mezcla estabilizante sinergistica.
ZA961076B (en) Methods of inhibiting cell-cell adhesion.
BG102040A (en) Beer brewing installation
YU5800A (sh) Univerzalno primenljiva krvna plazma
CA2149207A1 (en) Compounds that inhibit t cell proliferation and methods using the same
MX9204375A (es) Gen activador para la biosintesis de macrolidos.
CA2264066A1 (en) Antiparasitic compounds isolated from fermentation of nodulisporium sp
MX9707613A (es) Citostaticos modificados con hidratos de carbono.
AU3274793A (en) Enzymatic inverse polymerase chain reaction library mutagenesis
NZ320259A (en) Deodorizing preparations containing cationic biopolymers, aluminium hydrochlorate and esterase inhibitors
ZA965292B (en) Enzymatic composition.
MX9407877A (es) Sustrato de cultivo solido que incluye cebada.
AU3893493A (en) Micro-organisms, preparation method therefor and uses thereof
AU6700996A (en) Somatostatin-analogous cyclic peptides with inhibitory activity on growth hormone
GB2377060A (en) System for ranking financial underwriters
ZA961564B (en) Methods of inhibiting ovarian cancer.
AU4437485A (en) Inhibin isolated from ovarian follicular fluid
MX9803383A (es) Preparacion de nitrilos de arilo y vinilo.

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase